DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
The antitumor drugs camptothecin and an anilinoacridine, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (mAMSA), which act on DNA topoisomerase I and II, respectively, are shown to inhibit the growth of Saccharomyces cerevisiae mutants selected for their permeability to other inhibitors. In additio...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
1988
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC282219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2845409/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.85.20.7501 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|